Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 542 of 1,261
  1. US 10088485

    Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand

    Regen Biopharma, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  2. US 10087436

    Electrophysiologically mature cardiomyocytes and methods for making same

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  3. US 10087431

    Methods of generating nucleic acid fragments

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  4. US 10087444

    MicroRNA composition for the treatment of neuroblastoma

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  5. US 10087413

    Thin film cell encapsulation devices

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  6. US 10087252

    Methods and compositions for treating and preventing disease associated with αvβ5 integrin

    The Regents of the University of California · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  7. US 10087232

    Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy

    Protalix Ltd. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  8. US 10087230

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  9. US 10087211

    Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  10. US 10087210

    Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

    Ionis Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  11. US 10087229

    Peptide compound

    Takeda Pharmaceutical Company Limited · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  12. US 10086114

    Antimicrobial solutions with enhanced stability

    The Board of Regents of the University of Texas System · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  13. US 10086081

    Carbohydrate conjugated RNA agents and process for their preparation

    Alnylam Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  14. US 10085974

    Dosage and formulation

    Almirall, S.A. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  15. US 10087240

    DNA antibody constructs and method of using same

    Inovio Pharmaceuticals, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  16. US 10087181

    Compound as WNT signaling inhibitor, composition, and use thereof

    Curegenix, Inc. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  17. US 10086061

    Combination purified inactivated vaccine for flaviviruses

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted
  18. WO 2018175449

    COMPOSÉS DE PROLINE AMIDE ET LEURS ANALOGUES D'AZÉTIDINE PORTANT UN RADICAL BENZYLE À SUBSTITUTION SPÉCIFIQUE

    ABBVIE DEUTSCHLAND [DE] · Granted Sep 27, 2018 · Expires Sep 22, 2038

    granted
  19. EP 3378477

    NEUE THERAPEUTISCHE VERWENDUNGEN VON H3-LIGANDEN

    BIOPROJET PHARMA [FR] · Granted Sep 26, 2018 · Expires Sep 21, 2038

    granted
  20. US 10081621

    Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  21. US 10080376

    Method for enhancing postprocessing content of beneficial compounds in beverages naturally containing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  22. US 10081670

    Human antibodies to Ebola virus glycoprotein

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  23. US 10081669

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted
  24. US 10081626

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.